Learn more

EPITARGET AS

Overview
  • Total Patents
    33
  • GoodIP Patent Rank
    221,251
About

EPITARGET AS has a total of 33 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and machines are CELL BIOSCIENCES INC S, PENWEST PHARMACEUTICALS CO and ENCELADUS PHARMACEUTICALS B V.

Patent filings in countries

World map showing EPITARGET ASs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 12
#2 EPO (European Patent Office) 11
#3 United States 6
#4 Norway 4

Patent filings per year

Chart showing EPITARGET ASs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Machines

Top inventors

# Name Total Patents
#1 Nilssen Esben A 33
#2 Fossheim Sigrid L 24
#3 Lauten Cecilia Leal 15
#4 Evjen Tove J 9
#5 Rognvaldsson Karen Sibylla 6
#6 Juzenas Petras 5
#7 Roegnvaldsson Karen Sibylla 5
#8 Dumontet Charles 3
#9 Fossheim Sigrid 3
#10 Evjen Tove Julie 2

Latest patents

Publication Filing date Title
EP2819652A1 Use of a particulate immunomodulator in cancer therapy
WO2013129936A1 Use of an antibody and a particulate immunomodulator in therapy
EP2515861A2 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
WO2010143972A2 Acoustically sensitive drug delivery particles comprising inverted structure forming lipids
WO2010143970A2 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
EP2440182A2 Lipophilic drug carrier
WO2010143969A2 Acoustically sensitive drug delivery particles comprising phosphatidylethanolamine
EP2222279A2 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
EP2229183A1 Use of particles comprising an alcohol
WO2008120998A2 Acoustically sensitive drug delivery particles
WO2008035985A2 T1 mri trackable drug delivery particles, uses and methods thereof
WO2008033031A2 Mri trackable drug delivery particles, uses and methods thereof